Strategic Targeting for Optimal Prevention of Cancer
ConditionEarly Detection of Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65+
SponsorClinLogic LLC
About this trial
The primary goal of the study is to record data over the observation period to evaluate the clinical benefit of using hereditary cancer genomic diagnostics to assess overall hereditary genetic cancer risk profile and to help guide physicians to pursue preventative measures, which may lead to early detection and treatment of the condition.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
individuals, ages 65 years or older;
must have met medical necessity for hereditary cancer genomic testing and allowed the physician to test based on medical necessity;
hereditary cancer diagnostic test was ordered by a physician related to individual subject care considerations.
study subject has or had cancer
Disqualifiers
Study subjects will be excluded from the study if any of the following criteria apply: • study subject is currently hospitalized or incarcerated;
study subject is unable to provide an accurate history due to mental incapacity
study subject is currently abusing illicit and/or prescription drugs;
Trial population
Individuals, ages 65 years or older.
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
Genetic Testing
Diagnostic testBuccal swab
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Genomic cancer screen
A study subject is known to have personal and/or family history of cancer known to be influenced by genetic variation.
Time frame
120 Days2
Genomic cancer screen
A genotype known to be a predisposition for cancer.
Time frame
120 DaysSponsors and contacts
Click on the lead sponsor to view all of their trials.
ClinLogic LLC
Lead sponsor
MDGlobal
Collaborator
Source ClinicalTrials.gov